RECENT PATENTS ON SOLID DISPERSIONS OF ANTIHYPERLIPIDEMIC DRUGS

Hyperlipidemia is a worsening health condition in developed and developing countries, especially among the younger generation due to their lifestyle. The World Health Organization reported 2.6 million deaths globally due to hyperlipidemia. Therefore, there is a huge demand of antihyperlipidemic drugs in the pharmaceutical market. Approximately 60% of the total active drug content used in hyperlipidemia suffer from poor water solubility, particularly BCS class II drugs. Poor water solubility may result in insufficient absorption and finally affects the bioavailability of the drug causes ineffectiveness in lowering lipid profile of patients. In recent years, solid dispersion technology has proved to be a simple, effective and economical approach for industrial application to increase the solubility of these drugs. This review paper is an attempt to compile up various research as well as patents reports related to solid dispersions of poor water soluble antihyperlipidemic drugs.

• Publication year

  2023

• Venue

  International Journal of Applied Pharmaceutics

• Publication date

  2023-03-08

• Fields of study

  Not labeled

• Identifiers
  DOI 10.22159/ijap.2023v15i2.42402
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The characteristics and mechanism of co-administration of lovastatin solid dispersion with kaempferol to increase oral bioavailability

  2020cited by this paper
• Surface Wettability Modulated by Surfactant and Its Effects on the Drug Release and Absorption of Fenofibrate Solid Dispersions

  2019cited by this paper
• Effects of Polymer/Surfactant as Carriers on the Solubility and Dissolution of Fenofibrate Solid Dispersion

  2019cited by this paper
• Prevalence of hyperlipidemia in Shanxi Province, China and application of Bayesian networks to analyse its related factors

  2018cited by this paper
• A comparative assessment of nanocomposites vs. amorphous solid dispersions prepared via nanoextrusion for drug dissolution enhancement

  2017cited by this paper
• Physicochemical characterization of atorvastatin calcium/ezetimibe amorphous nano-solid dispersions prepared by electrospraying method

  2017cited by this paper
• Microwave Processed Solid Dispersions for Enhanced Dissolution of Gemfibrozil using non-Ordered Mesoporous Silica

  2017cited by this paper
• The effect of Pluronic F127 on the physicochemical properties and dissolution profile of lovastatin solid dispersions

  2016cited by this paper
• Dissolution study and thermal analysis of fenofibrate–Pluronic F127 solid dispersions

  2016cited by this paper
• Mechanistic insight into the dramatic improvement of probucol dissolution in neutral solutions by solid dispersion in Eudragit E PO with saccharin

  2016cited by this paper
• Solid dispersions of efonidipine hydrochloride ethanolate with improved physicochemical and pharmacokinetic properties prepared with microwave treatment.

  2016cited by this paper
• Thermal, spectroscopic and dissolution studies of lovastatin solid dispersions with acetylsalicylic acid

  2016cited by this paper
• Pharmacological and histological examination of atorvastatin-PVP K30 solid dispersions

  2015cited by this paper
• Characterization of Physicochemical Properties of Spray-dried Solid Dispersions Loaded with Unmodified Crystalline Fenofibrate

  2015cited by this paper
• Amorphous solid dispersion with increased gastric solubility in tandem with oral disintegrating tablets: a successful approach to improve the bioavailability of atorvastatin

  2015cited by this paper
• High speed electrospinning for scaled-up production of amorphous solid dispersion of itraconazole.

  2015cited by this paper
• Enhanced hypotensive effect of nimodipine solid dispersions produced by supercritical CO2 drying

  2015cited by this paper
• Development of omega-3 phospholipid-based solid dispersion of fenofibrate for the enhancement of oral bioavailability.

  2015cited by this paper
• Ball-milled solid dispersions of BCS Class IV drugs: Impact on the dissolution rate and intestinal permeability of acyclovir.

  2015cited by this paper
• Thermodynamically stable amorphous drug dispersions in amorphous hydrophilic polymers engineered by hot melt extrusion.

  2014cited by this paper
• Solubility and Bioavailability Enhancement of Poorly Aqueous Soluble Atorvastatin: In Vitro, Ex Vivo, and In Vivo Studies

  2014cited by this paper
• Microwave‐induced solid dispersion technology to improve bioavailability of glipizide

  2013cited by this paper
• Dissolution Improvement of Atorvastatin Calcium using Modified Locust Bean Gum by the Solid Dispersion Technique

  2013cited by this paper
• Enhanced Dissolution Profile and Antihyperlipedimic Activity of Simvastatin by Solid Dispersion with Pluronic F68

  2013cited by this paper
• Strategies to Address Low Drug Solubility in Discovery and Development

  2013cited by this paper
• Enhanced solubility and dissolution of simvastatin by HPMC-based solid dispersions prepared by hot melt extrusion and spray-drying method

  2013cited by this paper
• In vitro dissolution study of atorvastatin binary solid dispersion

  2013cited by this paper
• Use of polymer combinations in the preparation of solid dispersions of a thermally unstable drug by hot-melt extrusion

  2013cited by this paper
• Oral absorption of atorvastatin solid dispersion based on cellulose or pyrrolidone derivative polymers.

  2013cited by this paper
• Formulation and delivery of improved amorphous fenofibrate solid dispersions prepared by thin film freezing.

  2012cited by this paper
• Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement.

  2012cited by this paper
• Development and characterization of an atorvastatin solid dispersion formulation using skimmed milk for improved oral bioavailability

  2012cited by this paper
• Avoiding crystallization of lorazepam during infusion.

  2011cited by this paper
• [Stability of probucol-polyvinylpyrrolidone solid dispersion systems].

  2011cited by this paper
• Applicability of sucrose laurate as surfactant in solid dispersions prepared by melt technology.

  2011cited by this paper
• Spray drying technique. I: Hardware and process parameters.

  2010cited by this paper
• Spray drying technique: II. Current applications in pharmaceutical technology.

  2010cited by this paper
• In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion

  2010cited by this paper
• Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000.

  2009cited by this paper
• Enhanced bioavailability of probucol following the administration of solid dispersion systems of probucol-polyvinylpyrrolidone in rabbits.

  2009cited by this paper
• Influence of polyethylene glycol/polyethylene oxide on the release characteristics of sustained-release ethylcellulose mini-matrices produced by hot-melt extrusion: in vitro and in vivo evaluations.

  2009cited by this paper
• Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants.

  2009cited by this paper
• Influence of the microwave technology on the physical-chemical properties of solid dispersion with Nimesulide

  2009cited by this paper
• Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent.

  2009cited by this paper
• Preparation of a Solid Dispersion by a Dropping Methodto Improve the Rate of Dissolution of Meloxicam

  2008cited by this paper
• Characterization and Physical Stability of Spray Dried Solid Dispersions of Probucol and PVP-K30

  2008cited by this paper
• Physical characterization of lansoprazole/PVP solid dispersion prepared by fluid-bed coating technique

  2008cited by this paper
• Solubility Enhancement of Lovastatin by Modified Locust Bean Gum Using Solid Dispersion Techniques

  2008cited by this paper
• Evaluation of solid state properties of solid dispersions prepared by hot-melt extrusion and solvent co-precipitation.

  2008cited by this paper
• Cyclodextrins and their pharmaceutical applications.

  2007cited by this paper
• Salt formation to improve drug solubility.

  2007cited by this paper
• Pharmaceutical Applications of Hot-Melt Extrusion: Part I

  2007cited by this paper
• Preparation and study of PPV/PVA nanofibers via electrospinning PPV precursor alcohol solution

  2007cited by this paper
• Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.

  2007cited by this paper
• Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.

  2006cited by this paper
• Drug delivery to the upper small intestine window using gastroretentive technologies.

  2006cited by this paper
• Spray-Dried Amorphous Solid Dispersions of Simvastatin, a Low Tg Drug: In Vitro and in Vivo Evaluations

  2005cited by this paper
• Effect of a melt agglomeration process on agglomerates containing solid dispersions.

  2005cited by this paper
• Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method.

  2005cited by this paper
• Characterization of glass solutions of poorly water‐soluble drugs produced by melt extrusion with hydrophilic amorphous polymers

  2001cited by this paper
• The spray drying of pharmaceuticals

  1992cited by this paper
• Preparation, properties and ageing of tablets prepared from the chlorpropamide-urea solid dispersion

  1981cited by this paper
• Pharmaceutical applications of solid dispersion systems.

  1971cited by this paper
• Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates.

  1969cited by this paper
• Dissolution characteristics of reserpine‐polyvinylpyrrolidone co‐precipitates

  1969cited by this paper
• Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. I. Theoretical considerations and discussion of the literature.

  1966cited by this paper
• PROPERTIES OF FUSED MANNITOL IN COMPRESSED TABLETS.

  1964cited by this paper
• Studies on Absorption of Eutectic Mixture. I. A Comparison of the Behavior of Eutectic Mixture of Sulfathiazole and that of Ordinary Sulfathiazole in Man.

  1961cited by this paper

• EFFICACY OF PCSK9 INHIBITORS IN ADDITION TO BACKGROUND STATIN THERAPY COMPARED WITH PLACEBO IN ACHIEVING LDL-C TARGETS IN ADULTS WITH HYPERLIPIDAEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

  2026cites this paper
• EVALUATION OF HYPOLIPIDEMIC ACTIVITY OF OPUNTIA ELATIOR FRUIT JUICE IN HIGH-FAT DIET-INDUCED HYPERLIPIDEMIA IN WISTAR ALBINO RATS

  2025cites this paper
• Designing Antihyperlipidemic Oral Nano formulations using Quality by Design Principles: A Review of Recent Advances

  2025cites this paper
• STATINS: A NEW THERAPEUTIC APPROACH FOR THE TREATMENT OF NEUROPATHIC PAIN

  2024cites this paper